In last trading session, Cadrenal Therapeutics Inc (NASDAQ:CVKD) saw 0.46 million shares changing hands with its beta currently measuring 1.63. Company’s recent per share price level of $0.44 trading at -$0.06 or -11.73% at ring of the bell on the day assigns it a market valuation of $7.12M. That closing price of CVKD’s stock is at a discount of -393.18% from its 52-week high price of $2.17 and is indicating a premium of 18.18% from its 52-week low price of $0.36. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.42 million shares which gives us an average trading volume of 136.12K if we extend that period to 3-months.
Cadrenal Therapeutics Inc (NASDAQ:CVKD) trade information
Upright in the red during last session for losing -11.73%, in the last five days CVKD remained trading in the green while hitting it’s week-highest on Wednesday, 08/14/24 when the stock touched $0.44 price level, adding 28.01% to its value on the day. Cadrenal Therapeutics Inc’s shares saw a change of -39.87% in year-to-date performance and have moved 3.49% in past 5-day. Cadrenal Therapeutics Inc (NASDAQ:CVKD) showed a performance of 2.51% in past 30-days. Number of shares sold short was 48946.0 shares which calculate 0.7 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cadrenal Therapeutics Inc (CVKD) estimates and forecasts
Statistics highlight that Cadrenal Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -42.97% of value to its shares in past 6 months, showing an annual growth rate of 27.27% while that of industry is 17.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Cadrenal Therapeutics Inc (NASDAQ:CVKD)’s Major holders
Insiders are in possession of 46.72% of company’s total shares while institution are holding 2.09 percent of that, with stock having share float percentage of 3.93%. Investors also watch the number of corporate investors in a company very closely, which is 2.09% institutions for Cadrenal Therapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 30, 2024 , the former fund manager was holding 56.9 shares of worth $25315.0 or 0.36% of the total outstanding shares. The later fund manager was in possession of 4.12 shares on Jun 30, 2024 , making its stake of worth around $1832.0 in the company or a holder of 0.03% of company’s stock.
